DSOL Stock Overview
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Drug Free Solution, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.93% |
| 5 Year Change | -99.00% |
| Change since IPO | -99.96% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| DSOL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -3.4% | -1.7% |
| 1Y | n/a | -5.6% | 22.4% |
Return vs Industry: Insufficient data to determine how DSOL performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how DSOL performed against the US Market.
Price Volatility
| DSOL volatility | |
|---|---|
| DSOL Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DSOL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DSOL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jessica Bass | www.drugfreesolution.com |
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services.
Drug Free Solution, Inc. Fundamentals Summary
| DSOL fundamental statistics | |
|---|---|
| Market cap | US$88.89k |
| Earnings (TTM) | -US$867.71k |
| Revenue (TTM) | US$2.10k |
0.0x
P/S Ratio0.0x
P/E RatioIs DSOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSOL income statement (TTM) | |
|---|---|
| Revenue | US$2.10k |
| Cost of Revenue | US$212.65k |
| Gross Profit | -US$210.55k |
| Other Expenses | US$657.16k |
| Earnings | -US$867.71k |
Last Reported Earnings
Feb 28, 2014
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DSOL perform over the long term?
See historical performance and comparison